Skip to main content
Equibles

STATE STREET CORP

Position in NUVB — Nuvation Bio Inc.

CIK 93751 BOSTON, MA
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$41,866,109
+$12,758,773 QoQ
Shares Held
7,370,794
+8.6% QoQ
Ownership
2.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. NUVB ranks #128 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in NUVB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,866,109 7,370,794
2026-03-31 $29,107,336 6,784,927
2025-12-31 $52,494,686 5,858,782
2025-09-30 $22,529,984 6,089,185
2025-06-30 $10,840,018 5,558,984
2025-03-31 $8,546,588 4,856,016
2024-12-31 $12,235,981 4,599,993
2024-09-30 $9,541,149 4,166,441
2024-06-30 $11,608,197 3,975,410
2024-03-31 $11,078,376 3,043,510
2023-12-31 $4,623,943 3,062,214
2023-09-30 $4,059,054 3,029,145
2023-06-30 $5,438,602 3,021,446
2023-03-31 $4,637,055 2,793,407
2022-12-31 $5,102,807 2,657,712
2022-09-30 $6,877,691 3,070,398
2022-06-30 $9,551,889 2,948,114
2022-03-31 $15,763,415 2,996,847
2021-12-31 $23,239,306 2,734,036
2021-09-30 $13,947,171 1,403,136
2021-06-30 $8,569,901 920,505
2021-03-31 $444,125 42,500